Breaking News

Tweet TWEET

Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences

    Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences

PR Newswire

WASHINGTON, July 8, 2013

WASHINGTON, July 8, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA), a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous system
disorders, today announced that it will participate in two upcoming investor
conferences.

On Tuesday, July 9, 2013, the executive team will participate in the Piper
Jaffray Catalyst Symposium: Emerging Talent in Biopharma in Boston.

On Wednesday, July 10, 2013, Mihael Polymeropoulos, M.D., Vanda's President
and CEO, will deliver a corporate presentation at the JMP Securities
Healthcare Conference at 12:00 p.m. Eastern Time in New York City.

The JMP conference presentation will be available live on Vanda's corporate
website, where it will be archived for 30 days. To access this presentation,
go to Vanda's website at www.vandapharma.comand click on the "Presentations"
tab on the Investor Relations page. Please connect to the website several
minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of central
nervous system disorders. For more on Vanda Pharmaceuticals Inc., please
visit www.vandapharma.com.

Company Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.

Website: http://www.vandapharma.com
 
Press spacebar to pause and continue. Press esc to stop.